Related Experiment Videos
Is proteinuric pre-eclampsia a different disease in primigravida and multigravida?
A E Barden1, L J Beilin, J Ritchie
1University Department of Medicine, University of Western Australia, and Western Australian Heart Research Institute, Royal Perth Hospital, Australia. abarden@cyllene.uwa.edu.au
Clinical Science (London, England : 1979)
|September 24, 1999
Summary
Primigravid women with pre-eclampsia exhibit higher systolic blood pressure and hepatic dysfunction compared to multigravid women. However, key markers of endothelial dysfunction and fetal outcomes remain similar, suggesting no significant difference in pre-eclampsia pathophysiology based on parity.
Area of Science:
- Obstetrics and Gynecology
- Maternal-Fetal Medicine
- Pathophysiology of Pregnancy Complications
Background:
- Pre-eclampsia is a hypertensive disorder of pregnancy with potential risks for both mother and fetus.
- Parity, the condition of having borne offspring, is a known risk factor for pre-eclampsia.
- The potential influence of parity on the clinical presentation and underlying mechanisms of pre-eclampsia requires further investigation.
Purpose of the Study:
- To investigate whether clinical features and biochemical markers of endothelial dysfunction in proteinuric pre-eclampsia differ between primigravid and multigravid women.
- To explore if these differences suggest a distinct pathophysiology of pre-eclampsia based on parity.
- To assess the impact of parity on maternal and fetal outcomes in pre-eclampsia.
Main Methods:
- A comparative study involving 27 primigravid and 35 multigravid women diagnosed with pre-eclampsia.
- Clinical assessments included blood pressure, renal, hepatic, and coagulatory function markers.
- Biochemical markers of endothelial dysfunction, fetal outcomes (birthweight), and immune cell counts were measured ante-partum and post-partum.
Main Results:
- Primigravid women showed significantly higher ante-partum systolic blood pressure and more severe hepatic dysfunction (elevated aspartate aminotransferase).
- Renal function, proteinuria, platelet counts, and plasma volume markers were similar between groups.
- Fetal birthweight, endothelial dysfunction markers (urinary prostacyclin metabolite, plasma endothelin 1), and other biochemical markers did not differ significantly by parity.
Conclusions:
- Elevated systolic blood pressure and hepatic dysfunction in primigravid women suggest a potentially more severe presentation of pre-eclampsia.
- The lack of differences in birthweight and endothelial dysfunction markers does not support a different pathophysiology based on parity.
- Persistently higher white blood cell counts in primigravid women warrant further research into immune response differences in pre-eclampsia.